Neuropsychiatric Effects of Anabolic Steroids in Male Normal Volunteers

Tung Ping Su, Michael Pagliaro, Peter J. Schmidt, David Pickar, Owen Wolkowitz, David R. Rubinow

Research output: Contribution to journalArticle

Abstract

Objective.—To evaluate the acute effects of anabolic steroids on mood and behavior in male normal volunteers. Design.—A 2-week, double-blind (subject and rater), fixed-order, placebo-controlled crossover trial of methyltestosterone. Setting.—An inpatient research unit at the National Institutes of Health. Subjects.—A volunteer sample of 20 men who were medication free, free of medical and psychiatric illness, not involved in athletic training, and had no prior history of anabolic steroid use. Intervention.—A sequential trial for 3 days each of the following four drug conditions: placebo baseline, low-dose methyltestosterone (40 mg/d), high-dose methyltestosterone (240 mg/d), and placebo withdrawal. Main Outcome Measures.—Mood and behavioral ratings were completed during each drug condition and included both subjective and objective measures. Results.—Significant (P

Original languageEnglish (US)
Pages (from-to)2760-2764
Number of pages5
JournalJournal of the American Medical Association
Volume269
Issue number21
DOIs
StatePublished - Jun 2 1993
Externally publishedYes

Fingerprint

Testosterone Congeners
Methyltestosterone
Healthy Volunteers
Placebos
National Institutes of Health (U.S.)
Pharmaceutical Preparations
Cross-Over Studies
Sports
Psychiatry
Inpatients
Volunteers
Outcome Assessment (Health Care)
Research

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Su, T. P., Pagliaro, M., Schmidt, P. J., Pickar, D., Wolkowitz, O., & Rubinow, D. R. (1993). Neuropsychiatric Effects of Anabolic Steroids in Male Normal Volunteers. Journal of the American Medical Association, 269(21), 2760-2764. https://doi.org/10.1001/jama.1993.03500210060032

Neuropsychiatric Effects of Anabolic Steroids in Male Normal Volunteers. / Su, Tung Ping; Pagliaro, Michael; Schmidt, Peter J.; Pickar, David; Wolkowitz, Owen; Rubinow, David R.

In: Journal of the American Medical Association, Vol. 269, No. 21, 02.06.1993, p. 2760-2764.

Research output: Contribution to journalArticle

Su, TP, Pagliaro, M, Schmidt, PJ, Pickar, D, Wolkowitz, O & Rubinow, DR 1993, 'Neuropsychiatric Effects of Anabolic Steroids in Male Normal Volunteers', Journal of the American Medical Association, vol. 269, no. 21, pp. 2760-2764. https://doi.org/10.1001/jama.1993.03500210060032
Su, Tung Ping ; Pagliaro, Michael ; Schmidt, Peter J. ; Pickar, David ; Wolkowitz, Owen ; Rubinow, David R. / Neuropsychiatric Effects of Anabolic Steroids in Male Normal Volunteers. In: Journal of the American Medical Association. 1993 ; Vol. 269, No. 21. pp. 2760-2764.
@article{29ce69f0ccb240c1bcd38eb79a970ff0,
title = "Neuropsychiatric Effects of Anabolic Steroids in Male Normal Volunteers",
abstract = "Objective.—To evaluate the acute effects of anabolic steroids on mood and behavior in male normal volunteers. Design.—A 2-week, double-blind (subject and rater), fixed-order, placebo-controlled crossover trial of methyltestosterone. Setting.—An inpatient research unit at the National Institutes of Health. Subjects.—A volunteer sample of 20 men who were medication free, free of medical and psychiatric illness, not involved in athletic training, and had no prior history of anabolic steroid use. Intervention.—A sequential trial for 3 days each of the following four drug conditions: placebo baseline, low-dose methyltestosterone (40 mg/d), high-dose methyltestosterone (240 mg/d), and placebo withdrawal. Main Outcome Measures.—Mood and behavioral ratings were completed during each drug condition and included both subjective and objective measures. Results.—Significant (P",
author = "Su, {Tung Ping} and Michael Pagliaro and Schmidt, {Peter J.} and David Pickar and Owen Wolkowitz and Rubinow, {David R.}",
year = "1993",
month = "6",
day = "2",
doi = "10.1001/jama.1993.03500210060032",
language = "English (US)",
volume = "269",
pages = "2760--2764",
journal = "JAMA - Journal of the American Medical Association",
issn = "0098-7484",
publisher = "American Medical Association",
number = "21",

}

TY - JOUR

T1 - Neuropsychiatric Effects of Anabolic Steroids in Male Normal Volunteers

AU - Su, Tung Ping

AU - Pagliaro, Michael

AU - Schmidt, Peter J.

AU - Pickar, David

AU - Wolkowitz, Owen

AU - Rubinow, David R.

PY - 1993/6/2

Y1 - 1993/6/2

N2 - Objective.—To evaluate the acute effects of anabolic steroids on mood and behavior in male normal volunteers. Design.—A 2-week, double-blind (subject and rater), fixed-order, placebo-controlled crossover trial of methyltestosterone. Setting.—An inpatient research unit at the National Institutes of Health. Subjects.—A volunteer sample of 20 men who were medication free, free of medical and psychiatric illness, not involved in athletic training, and had no prior history of anabolic steroid use. Intervention.—A sequential trial for 3 days each of the following four drug conditions: placebo baseline, low-dose methyltestosterone (40 mg/d), high-dose methyltestosterone (240 mg/d), and placebo withdrawal. Main Outcome Measures.—Mood and behavioral ratings were completed during each drug condition and included both subjective and objective measures. Results.—Significant (P

AB - Objective.—To evaluate the acute effects of anabolic steroids on mood and behavior in male normal volunteers. Design.—A 2-week, double-blind (subject and rater), fixed-order, placebo-controlled crossover trial of methyltestosterone. Setting.—An inpatient research unit at the National Institutes of Health. Subjects.—A volunteer sample of 20 men who were medication free, free of medical and psychiatric illness, not involved in athletic training, and had no prior history of anabolic steroid use. Intervention.—A sequential trial for 3 days each of the following four drug conditions: placebo baseline, low-dose methyltestosterone (40 mg/d), high-dose methyltestosterone (240 mg/d), and placebo withdrawal. Main Outcome Measures.—Mood and behavioral ratings were completed during each drug condition and included both subjective and objective measures. Results.—Significant (P

UR - http://www.scopus.com/inward/record.url?scp=0027322147&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027322147&partnerID=8YFLogxK

U2 - 10.1001/jama.1993.03500210060032

DO - 10.1001/jama.1993.03500210060032

M3 - Article

C2 - 8492402

AN - SCOPUS:0027322147

VL - 269

SP - 2760

EP - 2764

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

SN - 0098-7484

IS - 21

ER -